» Authors » Teresa Dryl-Rydzynska

Teresa Dryl-Rydzynska

Explore the profile of Teresa Dryl-Rydzynska including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 8
Citations 17
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Milkowski A, Prystacki T, Marcinkowski W, Dryl-Rydzynska T, Zawierucha J, Malyszko J, et al.
Ren Fail . 2022 Jun; 44(1):946-957. PMID: 35652160
The phenomenon of patients with advanced renal failure accepted for dialysis at a late stage in the disease process (late referral [LR]) is known almost from the beginning of dialysis...
2.
Zawierucha J, Malyszko J, Malyszko J, Prystacki T, Marcinkowski W, Dryl-Rydzynska T
Front Endocrinol (Lausanne) . 2019 Feb; 10:40. PMID: 30804890
Secondary hyperparathyroidism (sHPT) is a common hormonal complication of chronic kidney disease. There are several therapeutic options for sHPT management aiming at calcium-phosphorus balance normalization and decrease of parathormone secretion....
3.
Malyszko J, Dryl-Rydzynska T, Marcinkowski W, Prystacki T, Malyszko J
Arch Med Sci . 2018 Jul; 14(4):941-944. PMID: 30002713
No abstract available.
4.
Malyszko J, Zawierucha J, Marcinkowski W, Prystacki T, Dryl-Rydzynska T, Malyszko J, et al.
Int Urol Nephrol . 2018 Jun; 50(8):1555-1556. PMID: 29868940
No abstract available.
5.
Zawierucha J, Malyszko J, Malyszko J, Prystacki T, Marcinkowski W, Dryl-Rydzynska T
Przegl Lek . 2018 Apr; 73(7):497-503. PMID: 29677420
Secondary hyperparathyroidism is one of the most common hormonal disorders associated with a chronic kidney disease. The main causes of this disease are associated with renal failure hyperphosphatemia, hypocalcemia, and...
6.
Zawierucha J, Malyszko J, Malyszko J, Prystacki T, Marcinkowski W, Dryl-Rydzynska T
Pol Arch Intern Med . 2017 Oct; 127(12):840-845. PMID: 29067991
INTRODUCTION    Secondary hyperparathyroidism (SHPT) is a common hormonal disorder associated with chronic kidney disease (CKD). The treatment of SHPT should lead to a reduction in parathormone concentrations by calcimimetics or...
7.
Zawierucha J, Malyszko J, Malyszko J, Dryl-Rydzynska T, Prystacki T, Marcinkowski W
Przegl Lek . 2016 Aug; 73(4):229-32. PMID: 27526425
Secondary hyperparathyroidism (sHPT) is a common complication being a consequence of metabolic disorders associated with chronic kidney disease (CKD). Treatment of the sHPT should lead to calcium-phosphate management stabilization and...
8.
Malyszko J, Milkowski A, Benedyk-Lorens E, Dryl-Rydzynska T
Arch Med Sci . 2016 Mar; 12(1):219-21. PMID: 26925140
No abstract available.